Related Experiment Video
Updated: Jan 14, 2026

08:00
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
13.9K
Construction of a Risk-Prediction Model for Severe Bone Marrow Suppression During Radiotherapy in Cervical Cancer
Zongtai Li1, Zhiyue Lin1, Peishan Qin1
1Department of Radiotherapy, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Clinical Medicine Insights. Oncology
|October 20, 2025
Summary
This study identified key risk factors for severe bone marrow suppression in cervical cancer patients undergoing radiotherapy. A visual nomogram tool was developed to predict and manage this risk, aiding early intervention.
Area of Science:
- Oncology
- Radiotherapy
- Hematology
Background:
- Cervical cancer patients undergoing radiotherapy face risks of severe bone marrow suppression.
- Identifying risk factors is crucial for patient management and treatment optimization.
Purpose of the Study:
- To examine risk factors for severe bone marrow suppression in cervical cancer patients during radiotherapy.
- To develop and validate a visual tool for predicting this risk.
Main Methods:
- Retrospective cohort study of 300 cervical cancer patients.
- Development of a nomogram prediction model using logistic regression.
- Validation of the nomogram's predictive performance using ROC curves, calibration curves, and DCA.
Main Results:
- Menopausal status, Karnofsky performance score (KPS), clinical stage, concurrent chemotherapy, and pre-radiotherapy creatinine levels were identified as independent risk factors.
- The nomogram demonstrated good predictive performance and clinical utility.
Conclusions:
- A nomogram model effectively predicts severe bone marrow suppression risk in cervical cancer patients undergoing radiotherapy.
- This tool supports individualized risk assessment and early intervention strategies.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Bone Marrow Sampling and Transplants
876
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
876

